Sandra Goble

PARP inhibitors: Synthetic lethality in the clinic

Olaparib for Metastatic Breast Cancer in Patients with a Germline BRCA Mutation

The Epidemiology of Obesity: A Big Picture

Accuracy of SOFA score in prediction of 30-day outcome of critically ill patients

BRCAness revisited

Procalcitonin as a diagnostic marker for sepsis: a systematic review and meta-analysis

Pancreatic cancer

PARP inhibitors for BRCA1/2-mutated and sporadic ovarian cancer: current practice and future directions

Clonal Heterogeneity and Tumor Evolution: Past, Present, and the Future

Impact of Obesity on Mortality and Complications in Trauma Patients

Physiologic, demographic and mechanistic factors predicting New Injury Severity Score (NISS) in motor vehicle accident victims

Acute respiratory distress syndrome

Trauma centre patient volume and inpatient mortality risk reconsidered

The European guideline on management of major bleeding and coagulopathy following trauma: fourth edition

Compliance with Recommended Care at Trauma Centers: Association with Patient Outcomes

Pediatric trauma-associated acute respiratory distress syndrome: Incidence, risk factors, and outcomes

The PI3K Pathway in Human Disease

Impact of withdrawal of care and futile care on trauma mortality

Using sulfuramidimidoyl fluorides that undergo sulfur(vi) fluoride exchange for inverse drug discovery

Moving from “optimal resources” to “optimal care” at trauma centers

Intracranial Pressure Monitoring in Severe Traumatic Brain Injury: Results from the American College of Surgeons Trauma Quality Improvement Program

Trends and outcome predictors after traumatic brain injury surgery: a nationwide population-based study in Taiwan

The effects of advance care planning on end-of-life care: A systematic review

Estimating the global incidence of traumatic brain injury

Laying a trap to kill cancer cells: PARP inhibitors and their mechanisms of action

Impact of a Bladder Cancer Diagnosis on Smoking Behavior

Guidelines for the Management of Severe Traumatic Brain Injury, Fourth Edition

Rucaparib Monotherapy in Patients With Pancreatic Cancer and a Known Deleterious BRCA Mutation

The Trauma Quality Improvement Program: Pilot Study and Initial Demonstration of Feasibility

The Trauma Quality Improvement Program of the American College of Surgeons Committee on Trauma

Creating a Nationally Representative Sample of Patients From Trauma Centers

Health Care Reform at Trauma Centers—Mortality, Complications, and Length of Stay

The Attributable Mortality and Length of Stay of Trauma-Related Complications

Centers for Medicare and Medicaid Services Quality Indicators Do Not Correlate With Risk-Adjusted Mortality at Trauma Centers

Trauma and Injury Severity Score (TRISS) Coefficients 2009 Revision

Methodology and Analytic Rationale for the American College of Surgeons Trauma Quality Improvement Program

Results of ARIEL2: A Phase 2 trial to prospectively identify ovarian cancer patients likely to respond to rucaparib using tumor genetic analysis.

Smoking Cessation Assistance for Patients With Bladder Cancer: A National Survey of American Urologists

Refinement of prespecified cutoff for genomic loss of heterozygosity (LOH) in ARIEL2 part 1: A phase II study of rucaparib in patients (pts) with high grade ovarian carcinoma (HGOC).